GlassScriptPhysician profile
Jugal Shah
NPI 1124439237
$5,596.66
in general payments reported to CMS, 2019-2025
14 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $181 · 2021: $2,359 · 2022: $1,852 · 2023: $359 · 2024: $611 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803 · Travel and Lodging: $336 · Education: $65.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.18 |
| Travel and Lodging | $336.39 |
| Education | $65.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $1,700.63 | 2021-2024 | Prodisc C Vivo |
| Nuvasive, INC. | $1,557.97 | 2020-2023 | Modulus |
| Globus Medical, INC. | $1,017.83 | 2021-2025 | Excelsiusgps Robotic Navigation System, Si-Lok, Excelsius Gps |
| Medtronic, INC. | $364.37 | 2021-2022 | |
| Cerapedics INC. | $263.63 | 2022-2023 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $217.87 | 2021-2022 | |
| Boston Scientific Corporation | $110.15 | 2021 | |
| Nevro Corp. | $93.27 | 2024 | Senza |
| Ethicon US, LLC | $73.84 | 2023-2025 | Stratafix, Dermabond Prineo, Surgiflo Hemostatic Matrix |
| Abbvie INC. | $63.53 | 2025 | |
| Si-Bone, INC. | $48.92 | 2022 | |
| Stryker Corporation | $31.29 | 2021-2022 | |
| Orthofix Medical, INC. | $26.81 | 2021 | |
| Ossdsign USA Incorporated | $26.55 | 2025 | Ossdsign Catalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jugal Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.